Literature DB >> 7609783

Adenosine inhibits the L-type calcium current in human atrial myocytes.

B Pelzmann1, P Schaffer, H Mächler, B Rigler, B Koidl.   

Abstract

The effects of adenosine on the L-type Ca2+ current (Ica) were studied in human atrial myocytes using the whole-cell voltage clamp technique. Ica was recorded under physiological calcium concentrations (1.8 mmol/l) at 37 degrees C. Under these conditions the current density of basal Ica averaged 4.0 pA/pF. Isoprenaline (1 mumol/l) increased basal Ica to 249.7%. Adenosine (100 mumol/l) in the presence of isoprenaline (1 mumol/l) decreased Ica from the level obtained with isoprenaline to 87.5% of basal Ica. Adenosine (0.1 to 100 mumol/l) also reduced basal Ica, maximally to 64.5% of control. Activation and inactivation parameters of basal Ica were not significantly different between adenosine (100 mumol/l) and control recordings. Our results show that adenosine affects both basal and isoprenaline stimulated Ica in human atrial myocytes. Although a considerable decrease of basal Ica was seen, we conclude that the action of adenosine on L-type Ca2+ current in human atrial myocytes is mainly antiadrenergic. Both effects may contribute to the antiarrhythmic properties of adenosine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609783     DOI: 10.1007/BF00233249

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes.

Authors:  P Schaffer; B Pelzmann; E Bernhart; P Lang; H Mächler; B Rigler; B Koidl
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes.

Authors:  M Rivet-Bastide; G Vandecasteele; S Hatem; I Verde; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

4.  Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes.

Authors:  B Koidl; P Flaschberger; P Schaffer; B Pelzmann; E Bernhart; H Mächler; B Rigler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

Review 5.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

6.  Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes.

Authors:  S M Bryant; G Hart
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Chronic heart failure increases negative chronotropic effects of adenosine in canine sinoatrial cells via A1R stimulation and GIRK-mediated IKado.

Authors:  Victor P Long; Ingrid M Bonilla; Stephen Baine; Patric Glynn; Sanjay Kumar; Karsten Schober; Kent Mowrey; Raul Weiss; Nam Y Lee; Peter J Mohler; Sandor Györke; Thomas J Hund; Vadim V Fedorov; Cynthia A Carnes
Journal:  Life Sci       Date:  2019-11-18       Impact factor: 5.037

8.  I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes.

Authors:  Susanne Scheruebel; Chintan N Koyani; Seth Hallström; Petra Lang; Dieter Platzer; Heinrich Mächler; Karl Lohner; Ernst Malle; Klaus Zorn-Pauly; Brigitte Pelzmann
Journal:  J Mol Cell Cardiol       Date:  2014-02-25       Impact factor: 5.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.